Trial Profile
Study to Evaluate OMR-12200 as a Negative Contrast Agent for Magnetic Resonance Cholangio-Pancreatography (2)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Ferric ammonium citrate (Primary)
- Indications Gastric disorders; Pancreatic disorders
- Focus Adverse reactions; Diagnostic use
- Sponsors Otsuka Pharmaceutical
- 03 Jun 2016 New trial record